Titre : Vibrio

Vibrio : Questions médicales fréquentes

Termes MeSH sélectionnés :

Polyhydramnios
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vibrio : Questions médicales les plus fréquentes", "headline": "Vibrio : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vibrio" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vibrionaceae", "url": "https://questionsmedicales.fr/mesh/D014737", "about": { "@type": "MedicalCondition", "name": "Vibrionaceae", "code": { "@type": "MedicalCode", "code": "D014737", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio alginolyticus", "alternateName": "Vibrio alginolyticus", "url": "https://questionsmedicales.fr/mesh/D044149", "about": { "@type": "MedicalCondition", "name": "Vibrio alginolyticus", "code": { "@type": "MedicalCode", "code": "D044149", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.030" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae", "alternateName": "Vibrio cholerae", "url": "https://questionsmedicales.fr/mesh/D014734", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae", "code": { "@type": "MedicalCode", "code": "D014734", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio cholerae non-O1", "alternateName": "Vibrio cholerae non-O1", "url": "https://questionsmedicales.fr/mesh/D044163", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae non-O1", "code": { "@type": "MedicalCode", "code": "D044163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.075" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O1", "alternateName": "Vibrio cholerae O1", "url": "https://questionsmedicales.fr/mesh/D041241", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O1", "code": { "@type": "MedicalCode", "code": "D041241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.151" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O139", "alternateName": "Vibrio cholerae O139", "url": "https://questionsmedicales.fr/mesh/D041242", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O139", "code": { "@type": "MedicalCode", "code": "D041242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Vibrio mimicus", "alternateName": "Vibrio mimicus", "url": "https://questionsmedicales.fr/mesh/D044164", "about": { "@type": "MedicalCondition", "name": "Vibrio mimicus", "code": { "@type": "MedicalCode", "code": "D044164", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.500" } } }, { "@type": "MedicalWebPage", "name": "Vibrio parahaemolyticus", "alternateName": "Vibrio parahaemolyticus", "url": "https://questionsmedicales.fr/mesh/D014736", "about": { "@type": "MedicalCondition", "name": "Vibrio parahaemolyticus", "code": { "@type": "MedicalCode", "code": "D014736", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.590" } } }, { "@type": "MedicalWebPage", "name": "Vibrio vulnificus", "alternateName": "Vibrio vulnificus", "url": "https://questionsmedicales.fr/mesh/D041261", "about": { "@type": "MedicalCondition", "name": "Vibrio vulnificus", "code": { "@type": "MedicalCode", "code": "D041261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Vibrio", "alternateName": "Vibrio", "code": { "@type": "MedicalCode", "code": "D014733", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jaime Martinez-Urtaza", "url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza", "affiliation": { "@type": "Organization", "name": "Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain." } }, { "@type": "Person", "name": "Jessica L Jones", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Jones", "affiliation": { "@type": "Organization", "name": "U.S. Food and Drug Administration Gulf Coast Seafood Laboratory 1 Iberville Drive UNITED STATES Dauphin Island AL 36528 2514068136." } }, { "@type": "Person", "name": "William C Walton", "url": "https://questionsmedicales.fr/author/William%20C%20Walton", "affiliation": { "@type": "Organization", "name": "2Auburn University Shellfish Laboratory, School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 150 Agassiz Street, Dauphin Island, AL 36528, USA." } }, { "@type": "Person", "name": "Julia C van Kessel", "url": "https://questionsmedicales.fr/author/Julia%20C%20van%20Kessel", "affiliation": { "@type": "Organization", "name": "Biology Department, Indiana University, Bloomington, Indiana, USA jcvk@indiana.edu." } }, { "@type": "Person", "name": "Blake Ushijima", "url": "https://questionsmedicales.fr/author/Blake%20Ushijima", "affiliation": { "@type": "Organization", "name": "Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Congenital chloride diarrhoea in a Chinese infant with a compound heterozygous SLC26A3 mutation.", "datePublished": "2024-05-04", "url": "https://questionsmedicales.fr/article/38704545", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-024-04788-x" } }, { "@type": "ScholarlyArticle", "name": "[Monochorionic biamniotic twin pregnancies outcomes in Reunion Island with indication of in utero transfert].", "datePublished": "2023-01-13", "url": "https://questionsmedicales.fr/article/36642329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gofs.2023.01.002" } }, { "@type": "ScholarlyArticle", "name": "Third trimester re-screening for gestational diabetes in morbidly obese women despite earlier negative test can reveal risks for obstetrical complications.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36494818", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jog.15515" } }, { "@type": "ScholarlyArticle", "name": "Prenatal Phenotype of Kabuki Syndrome: Seven Case Series.", "datePublished": "2022-11-25", "url": "https://questionsmedicales.fr/article/36436503", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000527551" } }, { "@type": "ScholarlyArticle", "name": "Severe Bartter syndrome type 1: Prompt postnatal management thanks to antenatal identification of SLC12A1 pathogenic variants.", "datePublished": "2022-09-01", "url": "https://questionsmedicales.fr/article/36058813", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.arcped.2022.08.011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Gammaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020563" }, { "@type": "ListItem", "position": 5, "name": "Vibrionaceae", "item": "https://questionsmedicales.fr/mesh/D014737" }, { "@type": "ListItem", "position": 6, "name": "Vibrio", "item": "https://questionsmedicales.fr/mesh/D014733" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vibrio - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vibrio", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vibrio", "description": "Comment diagnostiquer une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes tests sérologiques sont-ils utiles ?\nPeut-on diagnostiquer Vibrio par PCR ?\nQuels symptômes orientent vers un diagnostic de Vibrio ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vibrio", "description": "Quels sont les symptômes d'une infection à Vibrio ?\nLa diarrhée est-elle toujours présente ?\nLes infections à Vibrio causent-elles de la fièvre ?\nY a-t-il des symptômes graves associés ?\nLes symptômes apparaissent-ils rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vibrio", "description": "Comment prévenir les infections à Vibrio ?\nLe lavage des mains est-il important ?\nLes vaccinations existent-elles contre Vibrio ?\nFaut-il éviter certains aliments ?\nLes voyages augmentent-ils le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vibrio", "description": "Quel est le traitement principal pour Vibrio ?\nQuels antibiotiques sont efficaces contre Vibrio ?\nLa réhydratation est-elle toujours nécessaire ?\nLes traitements sont-ils différents selon le type de Vibrio ?\nLes probiotiques aident-ils dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vibrio", "description": "Quelles complications peuvent survenir avec Vibrio ?\nLa déshydratation est-elle une complication fréquente ?\nLes infections à Vibrio peuvent-elles être mortelles ?\nY a-t-il des risques pour les personnes immunodéprimées ?\nLes infections cutanées sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vibrio", "description": "Quels sont les principaux facteurs de risque pour Vibrio ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection ?\nLes personnes vivant près de l'eau sont-elles plus exposées ?\nLes voyages dans des zones endémiques sont-ils risqués ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Polyhydramnios&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection à Vibrio ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes à partir d'échantillons de selles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Vibrio ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des tests biochimiques spécifiques sont utilisés." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques ne sont généralement pas utilisés pour Vibrio." } }, { "@type": "Question", "name": "Peut-on diagnostiquer Vibrio par PCR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut être utilisée pour détecter l'ADN de Vibrio dans les échantillons." } }, { "@type": "Question", "name": "Quels symptômes orientent vers un diagnostic de Vibrio ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes gastro-intestinaux comme la diarrhée aiguë peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection à Vibrio ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre." } }, { "@type": "Question", "name": "La diarrhée est-elle toujours présente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la diarrhée est fréquente mais pas systématique dans les infections à Vibrio." } }, { "@type": "Question", "name": "Les infections à Vibrio causent-elles de la fièvre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre peut accompagner les infections à Vibrio, mais ce n'est pas toujours le cas." } }, { "@type": "Question", "name": "Y a-t-il des symptômes graves associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves peuvent inclure déshydratation et choc septique dans les cas sévères." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection." } }, { "@type": "Question", "name": "Comment prévenir les infections à Vibrio ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des fruits de mer crus ou mal cuits et lavez-vous les mains." } }, { "@type": "Question", "name": "Le lavage des mains est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le lavage des mains réduit le risque d'infection par Vibrio et d'autres pathogènes." } }, { "@type": "Question", "name": "Les vaccinations existent-elles contre Vibrio ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin efficace contre les infections à Vibrio." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, évitez les fruits de mer crus, surtout en période de chaleur ou d'épidémies." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est endémique augmente le risque d'infection." } }, { "@type": "Question", "name": "Quel est le traitement principal pour Vibrio ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la réhydratation, souvent accompagnée d'antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Quels antibiotiques sont efficaces contre Vibrio ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques comme la doxycycline et l'azithromycine sont souvent utilisés." } }, { "@type": "Question", "name": "La réhydratation est-elle toujours nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réhydratation est cruciale, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les traitements sont-ils différents selon le type de Vibrio ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut varier selon le type de Vibrio et la gravité de l'infection." } }, { "@type": "Question", "name": "Les probiotiques aident-ils dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais ne remplacent pas le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Vibrio ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la déshydratation sévère, le choc septique et l'insuffisance rénale." } }, { "@type": "Question", "name": "La déshydratation est-elle une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la déshydratation est une complication courante, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les infections à Vibrio peuvent-elles être mortelles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans les cas graves, les infections à Vibrio peuvent être mortelles sans traitement rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les personnes immunodéprimées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont à risque accru de complications graves." } }, { "@type": "Question", "name": "Les infections cutanées sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Vibrio peut causer des infections cutanées, surtout après des blessures en milieu aquatique." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour Vibrio ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'immunodépression." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves liées à Vibrio." } }, { "@type": "Question", "name": "Le diabète augmente-t-il le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut augmenter le risque d'infections graves à Vibrio." } }, { "@type": "Question", "name": "Les personnes vivant près de l'eau sont-elles plus exposées ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être plus exposées aux infections à Vibrio, surtout en été." } }, { "@type": "Question", "name": "Les voyages dans des zones endémiques sont-ils risqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est courant augmente le risque d'infection." } } ] } ] }

Sources (54 au total)

Congenital chloride diarrhoea in a Chinese infant with a compound heterozygous SLC26A3 mutation.

Congenital chloride diarrhoea (CCD) is an autosomal recessive condition that causes secretory diarrhoea and potentially deadly electrolyte imbalances in infants because of solute carrier family 26 mem... A 7-month-old Chinese infant with a history of maternal polyhydramnios presented with frequent watery diarrhoea, severe dehydration, hypokalaemia, hyponatraemia, failure to thrive, metabolic alkalosis... CCD should be considered when an infant presents with prolonged diarrhoea during infancy, particularly in the context of maternal polyhydramnios and dilated foetal bowel loops....

[Monochorionic biamniotic twin pregnancies outcomes in Reunion Island with indication of in utero transfert].

Complicated monochorionic biamniotic (MCBA) twin pregnancies may require treatment with fetoscopic laser photocoagulation, in case of Twin Oligo-Polyhydramnios Sequence or need of a selective terminat... Retrospective hospital study running from 2015 to 2018. We included all MCBA pregnancies between 15 and 25 weeks of gestation, with indications for in utero transfer. Our objective was to examine whet... Of the 23 patients, 17 (73.9%) benefited from sanitary transfers. The survival rate of the fetuses in 15 pregnancies with Twin Oligo-Polyhydramnios Sequence (TOPS) was 73.3% for one twin and 53.3% for... The sanitary transfer allows the management in expert center of complicated MCBA twin pregnancies, but is not always feasible and is accompanied by a high rate of premature ruptures of membranes....

Third trimester re-screening for gestational diabetes in morbidly obese women despite earlier negative test can reveal risks for obstetrical complications.

We investigated associations of maternal obesity with late gestational diabetes mellitus (GDM) diagnosis (>34 weeks) in women with previous normal glucose screening, and associations of late GDM with ... This retrospective cohort study assessed obstetrical and neonatal outcomes of 238 women with normal (24-28 week) glucose screening results, who underwent late repeat oral glucose tolerance tests (OGTT... The GDM rate in repeat OGTT screening was 22.2% for the total sample, and 33% among women with morbid obesity. Among women with late GDM versus without late GDM, rates were higher for macrosomia, larg... Late screening in pregnancy may reveal GDM among women with previous normal glucose screening, particularly among those with late third trimester BMI ≥ 35 kg/m...

Prenatal Phenotype of Kabuki Syndrome: Seven Case Series.

Kabuki syndrome (KS) is a multiple congenital anomaly syndrome with characterized facial features. The aim of study was to report on prenatal sonographic findings associated with KS in 7 Chinese famil... During the study period, 7 families of KS were diagnosed. Variants of KMT2D were detected in 4 cases, and variants of KDM6A in 3 cases. For cases with KMT2D variants, cleft palate was the only finding... Although there is no specific ultrasound feature which has both high sensitivity and high positive predictive value for KS, this disorder should be considered as a differential diagnosis in fetuses wi...

Cerebroplacental ratio and perinatal outcomes in mild-to-moderate idiopathic polyhydramnios cases.

This study will evaluate whether fetal cerebroplacental ratio (CPR) can predict perinatal adverse outcomes in singleton pregnancies with mild and moderate idiopathic polyhydramnios (IP).... This study was designed as a prospective case-control study between January 2023 and November 2023. Pregnant women diagnosed with mild-to-moderate IP and low-risk singleton pregnancies were included i... A total of 140 patients were included in the study. Seventy of these were IP cases, and 70 were low-risk pregnant women. UA PI in the IP group was not statistically different from that in the low-risk... It is encouraging that in cases with mild-to-moderate IP, low CPR predicts emergency delivery due to fetal distress, a low Apgar score at 5 min, and NICU admission....

Predicting the fetal weight by ultrasonography for isolated polyhydramnios: Comparison of 14 formulas.

To recalculate the estimated fetal weight (EFW) based on ultrasound measurements in patients complicated with isolated polyhydramnios, using 14 current formulas to observe which formula better predict... This study examined pregnant women who gave birth in the hospital between January 2015 and January 2020. Maximum vertical pocket (MVP) was classified as, mild, moderate, and severe polyhydramnios, and... A total of 564 polyhydramnios patients were included in the study. When looking at the MAPE, the lowest rate (7.65) was found in the Hadlock 2 formula. Hadlock 1, Hadlock 3, and Shinozuka formulas dem... The Hadlock 2 formula had the lowest MAPE in predicting birth weight in patients with polyhydramnios, closely followed by the Hadlock 1, Hadlock 3, and Shinozuka formulas....

A case of pregnancy with severe polyhydramnios related to long-term use of lithium.

Severe polyhydramnios during pregnancy may be associated with long-term lithium use and presents considerable challenges. This complication, which has been linked to induced nephrogenic diabetes insip... We present the case of a 42-year-old primigravida undergoing long-term lithium treatment for bipolar disorder type I, who developed severe polyhydramnios at 34 weeks of gestation. Clinical data includ... This case emphasizes the need for heightened awareness and proactive measures to mitigate the risk associated with lithium treatment during pregnancy. Close monitoring and timely interventions are ess... Our article puts forth the hypothesis that there is a link between lithium use during pregnancy and the occurrence of polyhydramnios and Nephrogenic Diabetes Insipidus (NDI), which may lead to severe ...

Relationship between increased maternal serum free human chorionic gonadotropin levels in the second trimester and adverse pregnancy outcomes: a retrospective cohort study.

A retrospective cohort study was conducted to collect the data of pregnant women who received hospital delivery in Hangzhou Women's Hospital from January 2018 to December 2020, and who participated in... We retrospectively analyzed the clinical data of 1,978 women in the elevated maternal serum free β-hCG group (free β-hCG ≥ 2.50 multiples of the median, MoM) and 20,767 women in the normal group (0.25... The gravidity and parity in the elevated free β-hCG group were lower, and the differences between the groups were statistically significant (all, P < 0.05). The risks of polyhydramnios, preeclampsia, ... APOs, such as polyhydramnios, preeclampsia, and hyperlipidemia, were increased risks of elevated free β-hCG levels, IUGR and female infants were also likely to happen. Furthermore, there was an associ...

Maternal outcomes of a cohort of pregnancies affected by non-immune hydrops fetalis.

To describe the maternal outcomes of a prospective cohort of non-immune hydrops fetalis (NIHF) pregnancies with negative standard-of-care evaluations.... This study was a secondary analysis of a prospective cohort study of NIHF pregnancies with negative work-ups (infection, alloimmune anemia, fetomaternal hemorrhage, and chromosomal disorders). Outcome... Forty pregnancies were included. Four patients developed pre-eclampsia (4/40, 10.0%); three occurred postpartum. None was diagnosed with mirror syndrome. Of the 31 continued pregnancies, 16 (51.6%) re... Our study identified several important adverse outcomes of pregnancies complicated by NIHF with negative standard-of-care evaluations, including a high rate of postpartum pre-eclampsia and worsened me...